| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics t...
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
The findings of the study showed the artificial intelligence (AI) model co-constructed by SOPHiA GENETICS and UroCCR provided a...
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $7 to $8.
RBC Capital analyst Conor McNamara reiterates Sophia Genetics (NASDAQ:SOPH) with a Outperform and maintains $8 price target.
Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company rep...
